SCHEMBL454438

SCHEMBL454438

CC(C)CCCCCC[CH]O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.43
HIF1A Q16665 3/20 0.34
EPAS1 Q99814 3/20 0.34
KDM4C Q9H3R0 2/20 0.33
TRPV1 Q8NER1 2/20 0.33
KDM4A O75164 1/20 0.33
PHF8 Q9UPP1 1/20 0.33
KDM2A Q9Y2K7 1/20 0.33
TRPA1 O75762 1/20 0.33
KDM1A O60341 1/20 0.32
TRPM8 Q7Z2W7 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
PTPN1 P18031 1/20 0.32
MEN1 O00255 1/20 0.32
CYP3A4 P08684 1/20 0.32
ALOX15 P16050 1/20 0.32
KMT2A Q03164 1/20 0.32
BLM P54132 1/20 0.32
CETP P11597 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11230053 1.00 LMNA (0.43) LMNAHIF1AEPAS1KDM4CTRPV1
SCHEMBL17956894 1.00 LMNA (0.43) LMNAHIF1AEPAS1KDM4CTRPV1
SCHEMBL17956865 1.00 LMNA (0.43) LMNAHIF1AEPAS1KDM4CTRPV1
SCHEMBL456201 1.00 LMNA (0.43) LMNAHIF1AEPAS1KDM4CTRPV1
SCHEMBL11237702 0.97
SCHEMBL6902324 0.89
SCHEMBL29227573 0.82 MAPT (0.47) TRPV1TRPA1TRPM8ALDH1A1MAPT
SCHEMBL28381453 0.82 MAPT (0.47) TRPV1TRPA1TRPM8ALDH1A1MAPT
SCHEMBL9054897 0.80 TRPV1 (0.31) TRPV1TRPA1TRPM8ALDH1A1MAPT
SCHEMBL7768868 0.80 LMNA (0.40) LMNAHIF1AEPAS1KDM4CTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3630049-A1 MICROCAPSULE SYSTEM FOR POLYSENSORY OLFACTORY EFFECTS II Henkel AG & Co. KGaA (DE) 2020-04-08 EP disclosed
US-20200093714-A1 MICROCAPSULE SYSTEM FOR POLYSENSORY OLFACTORY EFFECTS II HENKEL AG & CO. KGAA (DE) 2020-03-26 US disclosed
EP-2433617-B1 Cosmetic composition containing microcapsules HENKEL AG & CO KGAA (DE) 2019-05-15 EP disclosed
WO-2018215354-A1 MICROCAPSULE SYSTEM FOR POLYSENSORY OLFACTORY EFFECTS II HENKEL AG & CO. KGAA (DE) 2018-11-29 WO disclosed
EP-2756066-B1 AGENT CONTAINING MICROCAPSULES HENKEL AG & CO KGAA (DE) 2018-11-14 EP disclosed
EP-2544812-B1 IMPROVED MICROCAPSULES AND PRODUCTION THEREOF FOLLMANN GMBH & CO KG (DE) 2018-10-24 EP disclosed
EP-2614134-B1 MICROCAPSULE CONTAINING DETERGENT OR CLEANING AGENT HENKEL AG & CO KGAA (DE) 2017-11-08 EP disclosed
US-20170020794-A1 AGENT CONTAINING MICROCAPSULES HENKEL AG & CO. KGAA (DE) 2017-01-26 US disclosed
EP-3050919-A1 MIXTURES CONTAINING LIGNOCELLULOSIC MATERIALS WITH SALTS OF N-SUBSTITUTED CARBAMIC ACIDS BASF SE (DE) 2016-08-03 EP disclosed
EP-3039114-A1 MICROCAPSULE-CONTAINING DETERGENT OR CLEANING AGENT The Procter & Gamble Company (US) 2016-07-06 EP disclosed
US-20130137626-A1 MICROCAPSULES AND PRODUCTION THEREOF FOLLMANN & CO. GESELLSCHAFT FÜR CHEMIE-WERKSTOFFE UND VERFAHRENSTECHNIK MBH & CO. KG (DE) 2013-05-30 US disclosed
WO-2013037575-A1 AGENT CONTAINING MICROCAPSULES HENKEL AG & CO. KGAA (DE) 2013-03-21 WO disclosed
EP-2544812-A2 IMPROVED MICROCAPSULES AND PRODUCTION THEREOF Follmann & Co. Gesellschaft für Chemie-Werkstoffe und -Verfahrenstechnik mbH & Co. KG (DE) 2013-01-16 EP disclosed
US-20120122694-A1 VERBESSERTE MICROKAPSELN UND IHRE HERSTELLUNG IMPROVED MICROCAPSULES, AND THEIR PRODUCTION THEREOF Follmann & Co. Gesellschaft fur Chemie-Werkstoffe und Verfahrenstechnik mbH & Co. KG (DE) 2012-05-17 US disclosed
EP-2433617-A2 Cosmetic composition containing microcapsules Henkel AG & Co. KGaA (DE) 2012-03-28 EP disclosed
WO-2012032145-A1 MICROCAPSULE CONTAINING DETERGENT OR CLEANING AGENT HENKEL AG & CO. KGAA (DE) 2012-03-15 WO disclosed
EP-2406002-A2 IMPROVED MICROCAPSULES, AND PRODUCTION THEREOF Follmann & Co. Gesellschaft für Chemie-Werkstoffe und -Verfahrenstechnik mbH & Co. KG (DE) 2012-01-18 EP disclosed
WO-2011110368-A2 IMPROVED MICROCAPSULES AND PRODUCTION THEREOF FOLLMANN & CO. GESELLSCHAFT FÜR CHEMIE-WERKSTOFFE UND -VERFAHRENSTECHNIK MBH & CO. KG (DE) 2011-09-15 WO disclosed
EP-2364773-A1 Improved microcapsules and their manufacture Follmann & Co. Gesellschaft für Chemie-Werkstoffe und -Verfahrenstechnik mbH & Co. KG (DE) 2011-09-14 EP disclosed
WO-2010102830-A2 IMPROVED MICROCAPSULES, AND PRODUCTION THEREOF FOLLMANN & CO. GESELLSCHAFT FÜR CHEMIE-WERKSTOFFE UND VERFAHRENSTECHNIK MBH & CO. KG (DE) 2010-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122694-A1 VERBESSERTE MICROKAPSELN UND IHRE HERSTELLUNG IMPROVED MICROCAPSULES, AND THEIR PRODUCTION THEREOF VIM, ADH5, DCXR LMNA 2569/4885HIF1A 536/4885EPAS1 1919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.